UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments

Cancers, 2024-04, Vol.16 (7), p.1336

2024

Link zum Volltext

Verfügbarkeit prüfen

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1948-1957

2019

Link zum Volltext

Verfügbarkeit prüfen

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

The lancet oncology, 2016-12, Vol.17 (12), p.1697-1708

2016

Link zum Volltext

Verfügbarkeit prüfen

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

Journal of clinical oncology, 2021-01, Vol.39 (1), p.17-29

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology

Anticancer research, 2021-01, Vol.41 (1), p.369-378

2021

Link zum Volltext

Verfügbarkeit prüfen

Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types

International journal of cancer, 2021-04, Vol.148 (7), p.1676-1684

2021

Link zum Volltext

Verfügbarkeit prüfen

The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)

European journal of cancer (1990), 2013-03, Vol.49 (4), p.835-842

2013

Link zum Volltext

Verfügbarkeit prüfen

Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT

International journal of radiation oncology, biology, physics, 2017-11, Vol.99 (4), p.867-875

2017

Link zum Volltext

Verfügbarkeit prüfen

HER2 testing in gastric cancer diagnosis: Insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.15-15

2017

Link zum Volltext

Verfügbarkeit prüfen

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil

Anti-cancer drugs, 2004-06, Vol.15 (5), p.473-477

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) + FOLFIRI in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3536-3536

2015

Link zum Volltext

Verfügbarkeit prüfen

Rectal cancer: Neoadjuvant chemoradiotherapy

Baillière's best practice & research. Clinical gastroenterology, 2016-08, Vol.30 (4), p.629-639

2016

Link zum Volltext

Verfügbarkeit prüfen

ROAR: a phase 2, open-label study in patients (pts) with BRAF V600E–mutated rare cancers to investigate the efficacy and safety of dabrafenib (D) and trametinib (T) combination therapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS2604-TPS2604

2016

Link zum Volltext

Verfügbarkeit prüfen

Differential Effects of Sound Intervention and Rest on Cardiovascular Parameters in Cancer Patients: A Randomized Cross-over Trial

Integrative cancer therapies, 2021, Vol.20, p.1534735421995239-1534735421995239

2021

Link zum Volltext

Verfügbarkeit prüfen

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV)

International journal of clinical pharmacology and therapeutics, 2005-12, Vol.43 (12), p.590

2005

Link zum Volltext

Verfügbarkeit prüfen

Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?

Onkologie, 2003-04, Vol.26 (2), p.161

2003

Link zum Volltext

Verfügbarkeit prüfen

Klinischer Stellenwert der Bildgebung nach neoadjuvanter Therapie

MRT-basierte Chirurgie des Rektumkarzinoms, p.95-105

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

The New England journal of medicine, 2015-08, Vol.373 (8), p.726-736

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

British journal of cancer, 2019-01, Vol.120 (2), p.183-189

2019

Link zum Volltext

Verfügbarkeit prüfen

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Annals of oncology, 2018-04, Vol.29 (4), p.1010-1015

2018

Link zum Volltext

Verfügbarkeit prüfen

Liposomal encapsulated anti-cancer drugs

Anti-cancer drugs, 2005-08, Vol.16 (7), p.691-707

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(33)
Oncology
(32)
Female
(23)
Male
(23)
Aged
(22)
Middle Aged
(21)
Adult
(16)
Colorectal Cancer
(13)
Treatment Outcome
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Fluorouracil - Administration & Dosage
(10)
Leucovorin - Administration & Dosage
(10)
Tumors
(10)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(9)
Cancer
(9)
Chemotherapy
(9)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial

Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology

Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types

The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)

Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT

Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative

HER2 testing in gastric cancer diagnosis: Insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil

Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) + FOLFIRI in metastatic colorectal cancer (mCRC)

Rectal cancer: Neoadjuvant chemoradiotherapy

ROAR: a phase 2, open-label study in patients (pts) with BRAF V600E–mutated rare cancers to investigate the efficacy and safety of dabrafenib (D) and trametinib (T) combination therapy

Differential Effects of Sound Intervention and Rest on Cardiovascular Parameters in Cancer Patients: A Randomized Cross-over Trial

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV)

Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?

Klinischer Stellenwert der Bildgebung nach neoadjuvanter Therapie

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Liposomal encapsulated anti-cancer drugs

Suchergebnisse filtern